Skip to main content

00104/Autism An Open-Label Extension Study of CM-AT for the Treatment of Children with Autism

NCT02649959

An Open-Label Extension Study of CM-AT for the Treatment of Children with Autism

Associated Conditions

Autism

Principal Investigator

Sponsor

Curemark

The purpose of this research study is to test the safety, tolerability, and effectiveness of the pancreatic digestive enzyme, CM-AT, when used to treat Autistic Disorder. Enzymes are proteins naturally found in the body and can have many functions Digestive enzymes help the body digest food. CM-AT is an enzyme preparation, which is similar to the digestive enzymes naturally produced by the pancreas. In this study, CM-AT will be sprinkled on your child's food and given three times a day.